A cost-benefit analysis of a mandatory premarital rubella-antibody screening program.
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D003362:Cost-Benefit Analysis; D005260:Female; D006385:Hemagglutination Inhibition Tests / Q000191:economics; D006801:Humans; D007231:Infant, Newborn; D007883:Legislation, Medical; D008404:Massachusetts; D011291:Premarital Examinations / Q000191:economics*; D012041:Regional Medical Programs / Q000191:economics*; D012306:Risk; D012409:Rubella / Q000151:congenital / Q000191:economics / Q000517:prevention & control*; D012412:Rubella virus / Q000276:immunology
D000914:Antibodies, Viral